Patient Acquisition Economics: Why Hormone Leads Cost Less Than GLP Clicks
Everyone asks the same question about telehealth marketing: what does it cost to get a patient? Here is the honest structure of that answer, including numbers from our own ad accounts.
The GLP auction problem
GLP-1 keywords and audiences are among the most expensive real estate in consumer health advertising, because every operator from startups to public companies is bidding on the same intent. Brands competing head-on in that auction routinely describe patient acquisition costs running into the hundreds of dollars. It can still work, but it is the hard way in.
The side door: symptom-first acquisition
Here is what we do instead across our builds and our own brands. Instead of shouting GLP into a crowded room, we run creative that speaks to symptoms: the 3 a.m. wake-ups, the stubborn weight, the hair changes, the mood swings that women recognize instantly. The call to action is a simple lead form: what are you struggling with?
On our own hormone campaigns, recent symptom-qualified leads have cost between $1.77 and $2.58 each. Those are real figures from our ad manager, for our own brand. Ad results always vary with market, creative, offer, and budget, and lead cost is not the same as patient cost. But the strategic gap is the point: a warm, symptom-qualified woman for under three dollars, versus fighting a public company for a GLP click. And once she is in the funnel, the same brand can serve her GLP, hormone, and peptide needs alike. It is the side door to the same patient.
What happens after the click decides everything
Leads become patients through nurture, not pressure. Education-first text and email flows walk a lead from symptoms to understanding to care. Across our builds we have also measured that adding a human touchpoint for leads who stall mid-funnel lifts conversions meaningfully, in the range of seven to ten percent. That is a staffing decision worth more than most ad tweaks.
The unit math (an illustration, not a projection)
Telehealth ROI is a lifetime-value equation: what a patient pays monthly, times months retained, against what it cost to acquire them. As a clearly hypothetical illustration of the mechanics only: a panel of 200 subscribed patients averaging $150 in monthly contribution would represent $30,000 in monthly recurring revenue. That is arithmetic, not a promise. Your pricing, your retention, your market, and your execution set every input, and results vary widely. The reason the equation favors telehealth at all is retention, and retention is driven by real clinical care: labs, monitoring, follow-up, and education. That is precisely the layer most GLP-first platforms never built.
Three acquisition rules we give every founder
Do not discount at the front door. Price medium-high and let bundles, multi-month plans, and in-funnel offers do the discounting for the leads who need a nudge. You can come down. You cannot go up.
Be omnipresent before you are loud. A beautiful brand spending heavily on ads while its social profiles sit empty converts terribly, because patients check. Organic content is the trust layer paid traffic lands on.
Track end to end or you are guessing. Conversion pixels wired from ad to checkout are the difference between knowing which creative pays and burning budget in the dark.